FDA Approves LAMOTRIGINE — Unichem Pharmaceuticals (USA), Inc.
Unichem Pharmaceuticals (USA), Inc. announced the FDA approval of its oral LAMOTRIGINE generic formulation, a milestone that positions the company to compete for market share within the established anticonvulsant category.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day